Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Cluster_Neurowissenschaften_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
  • Research
  • Education
  • Press Review
 
Neuroscience /
 
Subnavigation
    News
     

    Gabriele Fischer nominated again for Scientific Advisory Board of the EU Drugs Monitoring Centre

    The internationally renowned addiction expert Gabriele Fischer from the University Department of..

     

    Lukas Haider awarded with the Karl-Vass-Multiple-Sclerosis research prize - Radiologist of MedUni Wien was honoured for research in the field of multiple sclerosis

    The Karl Vass Multiple Sclerosis Research Award was presented to Lukas Haider from the Department..

     

    Tweets regarding suicide prevention might prevent suicide

    A scientific team led by Thomas Niederkrotenthaler and Hannah Metzler from MedUni Vienna and..

     

    Light therapy relieves fatigue syndrome in Multiple Sclerosis

    Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is..

     

    Potential new lead compounds for the treatment of depression and anxiety disorders

    Currently, various classes of drugs are available for the treatment of mental illnesses - such as..

     

    Neuronal mechanism involved in the learning of maternal behaviour discovered

    Various conditions such as postpartum depression or postpartum psychosis can lead to an alteration..

     

    Depression manifests differently in men than in women

    Fewer men than women are diagnosed as having depression. One possible reason for this is that there..

     
    Treffer 1 bis 7 von 169
    << Erste < Vorherige Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Nächste > Letzte >>
     
Inhaltsbereich

New prognostic marker discovered for multiple sclerosis severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and, hence, the likelihood of disability. The results of the study have now been published in Neurology.

 

 

Researchers led by Gabriel Bsteh and Thomas Berger from the Department of Neurology at MedUni Vienna/University Hospital Vienna, working in collaboration with the Department of Ophthalmology and Optometrics at MedUni Vienna/University Hospital Vienna, studied 167 MS patients over a period of more than three years. They hypothesised that retinal damage due to relapse reflects the extent of damage in the brain. As the scientific analyses confirmed, the loss of approximately 5 µm (micrometres) of retinal layer thickness after optic neuritis equates to a doubling of the risk of permanent disability after the next relapse. These predictions could be used as the basis for treatment decisions in future: the results of the study suggest that more aggressive treatment is indicated where there is significant retinal layer thinning than would be the case for a smaller degree of thinning. This is true even if the patient has no disability or only slight disability at the time of measurement.

Prognostic technique already available
The researchers used optical coherence tomography (OCT) to measure retinal layer thickness. OCT is an imaging technique that uses infrared light to produce high-resolution three-dimensional images of very thin layers of tissue in the micrometre range (1 micrometre=1 thousandth of a millimetre). It is already used as a tool for diagnosing eye diseases such as glaucoma, and for evaluating disease progression. "The technique for predicting the course of MS is therefore already available to us," pointed out Gabriel Bsteh, first author of the study, adding: "As we discovered in the course of our clinical trial, measurements should be taken at initial diagnosis, directly when optic neuritis occurs in relapsing MS, and six months thereafter."

The retina as a window to the brain
Multiple sclerosis is a chronic inflammatory autoimmune disease that leads to the loss of axons and neurons throughout the entire nervous system. Although this damage often goes unnoticed by patients at first, its extent determines the prognosis for the severity of the disease. Since predictions about the course of the disease are important in MS for selecting the appropriate treatment, medical research has long been searching for reliable prognostic tools. "In retinal layer thickness, we have found a new biomarker that represents a window to the brain, as it were," said Gabriel Bsteh, summarising the essence of the study. If the results are confirmed in larger follow-up studies, the technique could also be applied in routine clinical practice.

Publication: Neurology
Retinal layer thinning after optic neuritis as a predictor of future relapse remission in relapsing multiple sclerosis
Gabriel Bsteh, Nik Krajnc, Katharina Riedl, Patrick Altmann, Barbara Kornek, Fritz Leutmezer, Stefan Macher, Christoph Mitsch, Philip Pruckner, Paulus Rommer, Gudrun Zulehner, Berthold Pemp, Thomas Berger
Doi: 10.1212/WNL.0000000000200970

 

 

zurück zu: Neuroscience
 
 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact